Detalhe da pesquisa
1.
Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice.
Proc Natl Acad Sci U S A
; 118(38)2021 09 21.
Artigo
Inglês
| MEDLINE | ID: mdl-34493582
2.
SARS-CoV-2 receptor binding domain displayed on HBsAg virus-like particles elicits protective immunity in macaques.
Sci Adv
; 8(11): eabl6015, 2022 Mar 18.
Artigo
Inglês
| MEDLINE | ID: mdl-35294244
3.
A modular protein subunit vaccine candidate produced in yeast confers protection against SARS-CoV-2 in non-human primates.
bioRxiv
; 2021 Jul 14.
Artigo
Inglês
| MEDLINE | ID: mdl-34282417
4.
Engineered SARS-CoV-2 receptor binding domain improves immunogenicity in mice and elicits protective immunity in hamsters.
bioRxiv
; 2021 Mar 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33688647